BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25510296)

  • 1. CD147 renal expression as a biomarker for progressive IgAN.
    Sun S; Zhao A; Li R; Du R; He L; Sun W; Wang H; Huang C
    J Nephrol; 2015 Jun; 28(3):307-14. PubMed ID: 25510296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of URG11 and Twist with clinical pathological characteristics and prognosis in patients with IgA nephropathy.
    Du R; Zhao L; Xia L; Liu L; Sun W; Zhao A; Yu Y; Han H; Sun S
    Nephrol Dial Transplant; 2013 Sep; 28(9):2268-76. PubMed ID: 23828164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
    Wang S; Dong L; Pei G; Jiang Z; Qin A; Tan J; Tang Y; Qin W
    Front Immunol; 2021; 12():700224. PubMed ID: 34456912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S; Yang X; Luo J; Guo H
    Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twist is a new prognostic marker for renal survival in patients with chronic kidney disease.
    Sun S; Du R; Xia L; Sun W; Zhai Y; Yu Y; Zhao A; Huang C; Ning X; Wang H
    Am J Nephrol; 2012; 35(2):141-51. PubMed ID: 22248584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy.
    van Es LA; de Heer E; Vleming LJ; van der Wal A; Mallat M; Bajema I; Bruijn JA; de Fijter JW
    Kidney Int; 2008 Jun; 73(12):1426-33. PubMed ID: 18354379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal expression of trefoil factor 3 mRNA in association with tubulointerstitial fibrosis in IgA nephropathy.
    Tanaka K; Sugiyama H; Yamanari T; Mise K; Morinaga H; Kitagawa M; Onishi A; Ogawa-Akiyama A; Tanabe K; Eguchi J; Ohmoto Y; Shikata K; Wada J
    Nephrology (Carlton); 2018 Sep; 23(9):855-862. PubMed ID: 29987860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nestin is a novel marker for renal tubulointerstitial injury in immunoglobulin A nephropathy.
    Tomioka M; Hiromura K; Sakairi T; Takeuchi S; Maeshima A; Kaneko Y; Kuroiwa T; Takeuchi T; Nojima Y
    Nephrology (Carlton); 2010 Aug; 15(5):568-74. PubMed ID: 20649878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
    Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y
    PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
    Fan Q; Lu R; Zhu M; Yan Y; Guo X; Qian Y; Zhang L; Dai H; Ni Z; Gu L
    Nephron; 2019; 142(3):195-207. PubMed ID: 30808829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.
    Zhang J; Wang C; Tang Y; Peng H; Ye ZC; Li CC; Lou TQ
    Nephrology (Carlton); 2013 Feb; 18(2):125-31. PubMed ID: 23134230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of tubulointerstitial plasmin in the progression of IgA nephropathy.
    Uchida T; Oda T; Takechi H; Matsubara H; Watanabe A; Yamamoto K; Oshima N; Sakurai Y; Kono T; Shimazaki H; Tamai S; Kumagai H
    J Nephrol; 2016 Feb; 29(1):53-62. PubMed ID: 25971850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubular and interstitial expression of ICAM-1 as a marker of renal injury in IgA nephropathy.
    Arrizabalaga P; Solé M; Abellana R; de las Cuevas X; Soler J; Pascual J; Ascaso C
    Am J Nephrol; 2003; 23(3):121-8. PubMed ID: 12566693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
    Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J
    Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
    Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
    Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
    Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanisms of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure.
    Chan LY; Leung JC; Lai KN
    Clin Exp Nephrol; 2004 Dec; 8(4):297-303. PubMed ID: 15619027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 expression in IgA nephropathy.
    Florquin S; Nunziata R; Claessen N; van den Berg FM; Pals ST; Weening JJ
    Am J Kidney Dis; 2002 Feb; 39(2):407-14. PubMed ID: 11840384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.